Sagility Ltd. Share Price

Overview

Sagility Ltd. share price is currently ₹45.52, up by ₹0.79 (1.77%) from its previous closing price of ₹44.73. The share price has gained 9.49% over the past month and gained 4.65% over the past year. The stock's 52-week low and high are ₹35.38 and ₹56.71, respectively. Sagility Ltd. has a market capitalisation of ₹ 21,370.00 Cr. The share price was last updated on 21 Sep 2026, 03:10 PM IST.

Sagility Ltd.
Sagility Ltd.
SAGILITY
 0.00
 0.79
1.77%
Business Services
 0.00(%)1D

Updated: 21 Sep 2026, 03:10:34 pm IST

Market Data

Open Price

 45.13

Prev. Close

 44.73
 45.13

Day Low

 46.17

Day High

 35.38

52 Week Low

 56.71

52 Week High

Business ServicesBusiness Support
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

21.47

Sector PE

26.77

PB Ratio

2.24

Sector PB

4.15

EPS

2.12

Dividend Yield

0.38

Today's Volume

20.711 M

5 Day Avg. Volume

17.055 M

PEG Ratio

0.30

Market Cap.

₹ 21,370.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 1% at ₹0.1/Share
07-Aug-202607-Aug-2026
DividendsInterim Dividend of 0.5% at ₹0.05/Share
12-Nov-202512-Nov-2025

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
ICICI Prudential Technology Fund - Growth7.46 Cr
7.46 Cr
no change
Canara Robeco Small Cap Fund - Regular Plan - Growth5.16 Cr
5.16 Cr
no change
Axis Small Cap Fund - Regular Plan - Growth5.15 Cr
5.15 Cr
no change
ICICI Prudential Innovation Fund - Regular Plan - Growth4.77 Cr
4.77 Cr
no change
Kotak Small Cap Fund - Growth4.65 Cr
4.65 Cr
no change

About Sagility Ltd. 👋

Sagility Ltd is a provider of technology-enabled business solutions and services to clients in the United States healthcare industry. Its clients include payers (United States health insurance companies, which finance and reimburse the cost of health services) and providers (primarily hospitals, physicians, and diagnostic and medical devices companies). Its services to payers cater to various aspects of their operations, including core benefits administration functions such as claims management, enrollment and benefits plan building, and clinical functions such as utilization management and care management. Its services to providers include revenue cycle management functions such as financial clearance, medical coding, billing, and accounts receivable follow-up services. It also provides some of the services that it provides to Payers to pharmacy benefit managers that manage prescription drugs for members (insured persons) under health insurance plans.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Shaly Gupta

Shaly Gupta

14 Sep • 1:16 PM · SEBI-Registered Analyst

Sagility's fundamental growth story remains strong.

SAGILITY
Sagility's fundamental growth story remains strong. It is a healthcare-focused BPM/technology-services company serving mainly US payers, providers and PBMs, and Q1 FY27 showed strong revenue and profit growth. The main concern is that margins have softened sequentially, while the stock valuation needs to keep pace with earnings growth. 🟢 Q1 FY27 performance Revenue: ₹1,963.5 crore, +27.6% YoY Adjusted EBITDA: ₹471.6 crore, +27.9% Adjusted EBITDA margin: 24.0% Adjusted PAT: ₹269.7 crore, +35.1% Constant-currency revenue growth was 15.2%. The reported revenue declined about 3% QoQ, but management/analysis indicates that seasonality in certain contracts was a major factor; on a constant-currency organic basis, the underlying sequential growth was healthier. 🚀 Key positive triggers 1. Healthcare BPM remains a structural growth market Sagility focuses on healthcare operations transformation for US payers, providers and PBMs, giving it exposure to a large and relatively specialised outsourcing market. The company has 47,000+ employees globally. 2. CareSeed acquisition The acquisition of CareSeed added 26 clients and strengthens Sagility's capabilities in HEDIS and risk adjustment, areas closely connected with Medicare Advantage. This can improve its ability to win higher-value healthcare contracts. 3. Strong client/deal momentum Q1 included $35.3 million of ACV, indicating continued demand for its services. However, investors should distinguish between organic client additions and those coming through acquisitions. 4. AI and automation opportunity Sagility is increasingly using analytics, automation and GenAI to improve healthcare operations. This can help increase productivity and potentially improve margins over the longer term.

See More
Sunil Kotak

Sunil Kotak

27 Aug • 3:46 PM · SEBI-Registered Analyst

Why technical retracements are important

SAGILITY
Why technical retracements are important SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Sagility chart weekly chart trendline drawn on charts we saw technical retracement on charts this is long term chart we have seen bounce back from levels on 36-39 this is crucial support zone on long term charts technical retracement levels are respected very gracefully generally. Other crucial information; Overall It sector is buy now for value investor. Be selective in IT sector Stay with mid to large cap stocks avoid small cap for now Large cap stocks are in acquisition mode for now. This is very good for the sector overall. All this is for information. This is not a buy/sell recommendation. Thank you, Technofunda24

See More
Tejaswi

Tejaswi

24 Jul • 5:51 AM · SEBI-Registered Analyst

Sagility’s Outsourcing Tailwind

SAGILITY
Sagility is gaining from a clear structural shift: more U.S. hospitals are outsourcing work to India, and that can support steady revenue growth for the company. For shareholders, this is generally positive because the business is tied to a large, recurring demand trend rather than a one-off event. Sagility’s latest reported numbers show strong momentum. Revenue for FY25 was about ₹1,971 crore, up 16.58% year on year, while net profit rose to ₹355 crore, up 273.38%. In the June 2025 quarter, revenue was ₹479.61 crore and net profit was ₹96.73 crore, with net margin at 20.47%. Another recent quarter showed revenue of ₹14,166 million, adjusted EBITDA of ₹3,690 million, EBITDA margin of 26.1%, adjusted PAT of ₹2,015 million, and adjusted EPS of ₹0.43. For shareholders, the benefit is straightforward: if U.S. healthcare clients keep shifting work to lower-cost Indian vendors, Sagility can expand volume, improve margins, and increase earnings. That usually helps valuation if execution stays strong. But there are also risks. The company is heavily exposed to U.S. healthcare outsourcing, so any slowdown in client spending, contract losses, pricing pressure, or regulatory changes could hurt growth. The stock can also become expensive if the market prices in too much future optimism too early. Overall, the trend looks beneficial for Sagility shareholders because it gives the company a long runway for growth and margin expansion. Still, the stock remains dependent on execution, client concentration, and sustained outsourcing demand.

See More
Sunil Kotak

Sunil Kotak

22 Jul • 10:09 AM · SEBI-Registered Analyst

Q1FY27 Quarterly Result Announced for Sagility Ltd.

Q1FY27 Quarterly Result Announced for Sagility Ltd.

SAGILITY
SEBI RA - Sunil Kotak - Shubh Consultancy - INH000015826 Commercial Services company Sagility announced Q1FY27 results Consolidated Financial Highlights: Total Income: For Q1FY27, total income reached Rs 19,778.06 million, a YoY growth of 27.70% from Rs 15,488.36 million in Q1FY26. On a QoQ basis, it decreased by 3.48% from Rs 20,490.36 million in Q4FY26. Revenue from Operations: Consolidated revenue for Q1FY27 stood at Rs 19,634.83 million, up 27.59% YoY from Rs 15,389.42 million in Q1FY26. It showed a QoQ decrease of 3.00% from Rs 20,242.57 million in Q4FY26. Profit Before Tax (PBT): For Q1FY27, PBT was Rs 2,874.78 million, representing a YoY increase of 36.64% from Rs 2,103.87 million in Q1FY26. Compared to Q4FY26, which was Rs 3,631.84 million, PBT decreased by 20.84% QoQ. Net Profit for the Period: The company reported a net profit of Rs 2,168.11 million in Q1FY27, reflecting a YoY growth of 45.94% from Rs 1,485.59 million in Q1FY26. On a QoQ basis, it decreased by 15.87% from Rs 2,577.27 million in Q4FY26. Earnings Per Share (EPS): Basic EPS for Q1FY27 stood at Rs 0.46, compared to Rs 0.32 in Q1FY26 and Rs 0.56 in Q4FY26. Total Comprehensive Income: Total comprehensive income for Q1FY27 was Rs 2,614.10 million, compared to Rs 1,483.50 million in Q1FY26 and Rs 4,652.87 million in Q4FY26. All this is for information This is not a buy/sell recommendation. Thank you, Technofunda24

See More
DHARMESH BHATT             R A

DHARMESH BHATT R A

21 Jul • 8:55 PM · SEBI-Registered Analyst

Sagiity : Rsult update

SAGILITY
Total Income: For Q1FY27, total income reached Rs 19,778.06 million, a YoY growth of 27.70% from Rs 15,488.36 million in Q1FY26. On a QoQ basis, it decreased by 3.48% from Rs 20,490.36 million in Q4FY26. Revenue from Operations: Consolidated revenue for Q1FY27 stood at Rs 19,634.83 million, up 27.59% YoY from Rs 15,389.42 million in Q1FY26. It showed a QoQ decrease of 3.00% from Rs 20,242.57 million in Q4FY26. Profit Before Tax (PBT): For Q1FY27, PBT was Rs 2,874.78 million, representing a YoY increase of 36.64% from Rs 2,103.87 million in Q1FY26. Compared to Q4FY26, which was Rs 3,631.84 million, PBT decreased by 20.84% QoQ. Net Profit for the Period: The company reported a net profit of Rs 2,168.11 million in Q1FY27, reflecting a YoY growth of 45.94% from Rs 1,485.59 million in Q1FY26. On a QoQ basis, it decreased by 15.87% from Rs 2,577.27 million in Q4FY26. Earnings Per Share (EPS): Basic EPS for Q1FY27 stood at Rs 0.46, compared to Rs 0.32 in Q1FY26 and Rs 0.56 in Q4FY26. Total Comprehensive Income: Total comprehensive income for Q1FY27 was Rs 2,614.10 million, compared to Rs 1,483.50 million in Q1FY26 and Rs 4,652.87 million in Q4FY26.

See More
Prameela Balakkala

Prameela Balakkala

21 Jul • 6:48 PM · SEBI-Registered Analyst

SAGILITY Posts Strong Q1 Growth: Profit and Margins on the Rise

SAGILITY
📈 SAGILITY’s Q1 performance signals robust momentum with significant year-on-year gains. ✅ Net Profit jumps to ₹217 Cr from ₹149 Cr YoY, reflecting healthy bottom-line growth. 💰 Revenue climbs to ₹1,963 Cr versus ₹1,539 Cr a year ago, showcasing solid top-line expansion. 📊 EBITDA surges to ₹440 Cr from ₹284 Cr YoY, underlining improved operational efficiency. 🔑 EBITDA Margin expands to 22.32% compared to 18.47% last year, highlighting better cost management.

See More

Frequently Asked Questions

What is the share price of Sagility Ltd.?

What is the market cap of Sagility Ltd.?

Should I buy Sagility Ltd. stock now?

What is the 52 week high and low of Sagility Ltd.?

Is the Sagility Ltd. stock good to buy?

Is Sagility Ltd. a good buy for the long term?

Is Sagility Ltd. overvalued or undervalued?

What is the PE and PB ratio of Sagility Ltd.?

Start Now